Skip to content
Search

Latest Stories

GPhC, PSNI empowered to define roles of responsible, superintendent and chief pharmacists

New legislative orders approved by the Privy Council will give the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI) powers to set professional standards for Responsible Pharmacists, Superintendent Pharmacists and Chief Pharmacists.

The Pharmacy (Preparation and Dispensing Errors – Hospital (and Other Pharmacy Services) Order 2022 and the Pharmacy (Responsible Pharmacists, Superintendent Pharmacists etc.) Order 2022 have been published and are expected to come into force in December 2022.


Trevor Patterson, Chief Executive of the Pharmaceutical Society NI said: “We have been working with our colleagues in the GPhC and Government for some time on these two pieces of important legislation and we are delighted they have now reached the statute books.

“Both Orders enable and enhance the powers we, and the GPhC, have to define the roles and responsibilities of Responsible, Superintendent and Chief Pharmacists, respectively. They also create protections against criminal prosecution for hospital pharmacists where an inadvertent error is made either in dispensing or assembly, in certain defined circumstances, similar to the protections available to colleagues working in community/registered pharmacy settings. Provisions that allow the appointment of a Deputy Registrar for our organization will also be introduced.

“The Pharmacy (Responsible Pharmacists, Superintendent Pharmacists etc.) Order 2022 will transfer responsibility from ministers to regulators to set standards for Superintendent and Responsible Pharmacists, creating greater flexibility in a rapidly evolving health service where patient safety is at the forefront.

“Throughout its development, we have fully supported the aims of the Hospital (and Other Pharmacy Services) Order 2022, which will be supportive to registrants and further encourage an open and candid working culture, one in which mistakes are recognised and rectified enhancing patient safety at all levels and where a learning culture can be embedded in everyday practice.

“Once these powers have commenced, on 1 December 2022, we will work with our partners in the GPhC, the Northern Ireland pharmacy community and with other stakeholders to develop the appropriate Professional Standards and Guidance to underpin good pharmacy practice, thus supporting and enhancing modern and safe patient care.”

Duncan Rudkin, Chief Executive of the GPhC, said: “These orders will enable the GPhC and PSNI to take forward important work to strengthen pharmacy governance. New standards will complement our existing standards for all pharmacy professionals to which these groups are already committed.

“We also welcome the changes the Pharmacy (Preparation and Dispensing Errors – Hospital and Other Pharmacy Services) Order 2022 will make to the Medicines Act. These changes will enable pharmacy professionals working in settings including hospitals and prisons to have protection from prosecution in the event of a dispensing or assembly error, provided certain preconditions are satisfied. Previously this protection from prosecution was only available to pharmacy professionals working at a registered pharmacy.

“We strongly support extending this protection from prosecution to pharmacy professionals working in other settings, as we believe this promotes an open and learning culture. This will increase the opportunities for pharmacy teams to learn from dispensing errors and reduce the possibility of them happening again, which is vital for patient safety.”

“We are committed to listening carefully to all views expressed and considering what approach would best support safe and effective pharmacy care.

GPhC will move onto drafting the rules and professional standards and will hold full public consultations to make sure that the rules and the standards reflect the views and needs of patients and the public, health professionals, the NHS and the wider health sector.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less